EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Healthcare resource utilisation and direct medical cost for individuals with 5q spinal muscular atrophy in Sweden

Thomas Sejersen, Sophie Graham, Anne-Berit Ekström, Anna-Karin Kroksmark, Marta Kwiatkowska, Michael L Ganz, Nahila Justo, Karl Gertow, Alex Simpson

The European Journal of Health Economics · 2025

DOI: 10.1007/s10198-024-01678-y ↗

Kurz gefasst

Fachartikel in der Zeitschrift The European Journal of Health Economics, 2025. Verfasst von Thomas Sejersen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Child Neurology, Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden. Hauptthemen laut MEDLINE: Muscular Atrophy, Spinal, Health Care Costs, Patient Acceptance of Health Care, Health Resources. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: F. Hoffmann-La Roche.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Spinal muscular atrophy (SMA) is a rare, progressive, neuromuscular disorder. Recent advances in treatment require an updated assessment of burden to inform reimbursement decisions.

Objectives

To quantify healthcare resource utilisation (HCRU) and cost of care for patients with SMA.

Methods

Cohort study of patients with SMA identified in the Swedish National Patient Registry (2007–2018), matched to a reference cohort grouped into four SMA types (1, 2, 3, unspecified adult onset [UAO]). HCRU included inpatient admissions, outpatient visits, procedures, and dispensed medications. Direct medical costs were estimated by multiplying HCRU by respective unit costs. Average annual HCRU and medical costs were modelled for SMA versus reference cohorts to estimate differences attributable to the disease (i.e., average treatment effect estimand). The trajectory of direct costs over time were assessed using synthetic cohorts.

Results

We identified 290 SMA patients. Annualised HCRU was higher in SMA patients compared with reference cohorts. Highest risk ratios were observed for inpatient overnight stays for type 1 (risk ratio [RR]: 29.2; 95% confidence interval [CI]: 16.0, 53.5) and type 2 (RR: 23.3; 95% CI: 16.4,33.1). Mean annual direct medical costs per patient for each year since first diagnosis were greatest for type 1 (€114,185 and SMA-attributable: €113,380), type 2 (€61,876 and SMA-attributable: €61,237), type 3 (€45,518 and SMA-attributable: €44,556), and UAO (€4046 and SMA-attributable: €2098). Costs were greatest in the 2–3 years after the first diagnosis for all types. Discussion and conclusion The economic burden attributable to SMA is significant. Further research is needed to understand the burden in other European countries and the impact of new treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Muscular Atrophy, SpinalHealth Care CostsPatient Acceptance of Health CareHealth ResourcesHealth ExpendituresHumansSwedenMaleFemaleAdultAdolescentChildChild, PreschoolYoung AdultMiddle AgedRegistriesInfantHospitalizationCohort Studies

Stichwörter der Autor:innen

Cohort studyDirect medical costsHealthcare resource useRegistriesSpinal muscular atrophySweden

Autor:innen und Institutionen

  • Department of Child Neurology, Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden.
  • Department of Women's and Children's Health, Karolinska Institute, Stockholm, Sweden.
  • Center for Neuromusculoskeletal Restorative Medicine, Hong Kong Science Park, Shatin, New Territories, Hong Kong.
  • Evidera Ltd, London, UK.
  • Pediatric Rehabilitation Center, Queen Silvia Children's Hospital, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Department of Pediatrics, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Förderung

  • F. Hoffmann-La Roche

Zitieren

APA

Sejersen, T., Graham, S., Ekström, A. B., Kroksmark, A. K., Kwiatkowska, M., Ganz, M. L., Justo, N., Gertow, K., & Simpson, A. (2025). Healthcare resource utilisation and direct medical cost for individuals with 5q spinal muscular atrophy in Sweden. The European Journal of Health Economics. https://doi.org/10.1007/s10198-024-01678-y

Vancouver

Sejersen T, Graham S, Ekström AB, Kroksmark AK, Kwiatkowska M, Ganz ML, et al. Healthcare resource utilisation and direct medical cost for individuals with 5q spinal muscular atrophy in Sweden. The European Journal of Health Economics. 2025. doi:10.1007/s10198-024-01678-y

BibTeX
@article{Sejersen2025,
  author = {Sejersen, Thomas and Graham, Sophie and Ekström, Anne-Berit and Kroksmark, Anna-Karin and Kwiatkowska, Marta and Ganz, Michael L and Justo, Nahila and Gertow, Karl and Simpson, Alex},
  title = {Healthcare resource utilisation and direct medical cost for individuals with 5q spinal muscular atrophy in Sweden},
  journal = {The European Journal of Health Economics},
  year = {2025},
  doi = {10.1007/s10198-024-01678-y}
}
Kostenlos starten →